🇺🇸 FDA
Patent

US 8791151

Crystalline form of a 3-phenoxymethylpyrrolidine compound

granted A61KA61K31/40A61K45/06

Quick answer

US patent 8791151 (Crystalline form of a 3-phenoxymethylpyrrolidine compound) held by Theravance Biopharma R&D IP, LLC expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/40, A61K45/06, A61P, A61P13/00